MedTrace Logo

Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19

NCT04376788 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-07-09

No results posted yet for this study

Summary

The aim of this project is to introduce way for treatment of patients with severe COVID-19 disease with respiratory complications.

Conditions

Interventions

BIOLOGICAL

exchange blood transfusion from normal donor

IV method

BIOLOGICAL

plasma from convalescent patients with COVID-19

IV method

DRUG

Methylene Blue 5 MG/ML

IV method

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mohamed M Moussa, MD · Ain Shams University

  • Ayman I Tharwat, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2020-07-01
Completion
2020-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04376788 on ClinicalTrials.gov